Clinical trial
Conbercept in Choroidal Neovascularization Secondary to Uveitis
NCT02934841 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Conbercept in Choroidal Neovascularization Secondary to Uveitis
- Lead sponsor
- Chongqing Medical University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 30, 2016
- Completion date
- November 30, 2018
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.